Pelish Henry E. 4

4 · Nuvalent, Inc. · Filed Oct 17, 2025

Form 4

Period: 2025-10-15

Chief Scientific Officer

Transactions

Exercise/Conversion
Class A Common Stock
2025-10-15$27.85/sh+7,495$208,736→ 77,126 total
Exercise/Conversion
Class A Common Stock
2025-10-15$72.35/sh+3,042$220,089→ 80,168 total
Sale
Class A Common Stock
2025-10-15$90.04/sh−14,205$1,279,018→ 65,963 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-10-15−3,042→ 24,058 total
Exercise: $72.35Exp: 2034-01-05→ Class A Common Stock (3,042 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-10-15−7,495→ 13,156 total
Exercise: $27.85Exp: 2033-01-06→ Class A Common Stock (7,495 underlying)
Exercise/Conversion
Class A Common Stock
2025-10-15$18.93/sh+3,668$69,435→ 69,631 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-10-15−3,668→ 10,569 total
Exercise: $18.93Exp: 2032-01-04→ Class A Common Stock (3,668 underlying)

Footnotes (5)

[F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2024.
[F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.84 to $90.23, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price.
[F3]The shares underlying this option vest as follows: 25% of the shares vested on January 4, 2023, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
[F4]The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
[F5]The shares underlying this option have vested or shall vest over the four years following January 5, 2024 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

Documents

1 file